Information Provided By:
Fly News Breaks for September 26, 2016
VASC
Sep 26, 2016 | 06:39 EDT
Piper Jaffray analyst Brooks West raised his price target for Vascular Solutions to $56 after hosting investor meetings with management. Investors should continue to add or initiate positions in Vascular as the stock remains undervalued, West tells investors in a research note. The shares reflect modest, if any, value for the "compelling" RePlas and large bore product opportunities, the analyst contends. He keeps an Overweight rating on Vascular Solutions.
News For VASC From the Last 2 Days
There are no results for your query VASC